Page last updated: 2024-11-02

pioglitazone and Mood Disorders

pioglitazone has been researched along with Mood Disorders in 1 studies

Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.

Mood Disorders: Those disorders that have a disturbance in mood as their predominant feature.

Research Excerpts

ExcerptRelevanceReference
"Mood disorders and type 2 diabetes mellitus (T2DM) are prevalent conditions that often co-occur."3.01Clinical insights into the cross-link between mood disorders and type 2 diabetes: A review of longitudinal studies and Mendelian randomisation analyses. ( Fabbri, C; Fanelli, G; Possidente, C; Serretti, A, 2023)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Possidente, C1
Fanelli, G1
Serretti, A1
Fabbri, C1

Reviews

1 review available for pioglitazone and Mood Disorders

ArticleYear
Clinical insights into the cross-link between mood disorders and type 2 diabetes: A review of longitudinal studies and Mendelian randomisation analyses.
    Neuroscience and biobehavioral reviews, 2023, Volume: 152

    Topics: Depressive Disorder, Major; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Mood Disorders;

2023